Lymphedema in Endometrial Cancer

N/ACompletedNCT01914276

Duke University100 enrolled

Overview

Objectives: (1) To determine the incidence of lower-extremity lymphedema after staging surgery for endometrial cancer; (2) to describe lymphedema-related morbidity after staging surgery for endometrial cancer and (3) to evaluate pre- and post-operative quality of life in women with endometrial cancer who undergo staging surgery. Data analysis and risk/safety issues: The proposed study will consist of a convenience sample of women who undergo minimally invasive surgery for endometrial cancer over a 1 year period. The investigators anticipate enrollment of 75 to 100 women. Frequency tables and difference with its 95% exact confidence intervals between pre-and post-operative lower extremity lymphedema measurements and quality of life questionnaires will be estimated.

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Lower Extremity Lymphedema Endometrial Cancer

Eligibility

Sex: FEMALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. women older than 18 years old, 2. endometrial cancer, 3. suitable candidates for surgery, 4. scheduled to undergo laparoscopy or robotic-assisted (RA) laparoscopy for endometrial cancer at Duke University Medical Center (DUMC), 5. no severe physical or mental comorbidity Exclusion Criteria: 1. metastatic disease, 2. laparotomy

Locations (1)

Outcomes

Primary Outcomes

change in incidence of lower-extremity lymphedema

Time frame: 1 month, 6-9 months and 12-18 months after staging surgery for endometrial cancer

Secondary Outcomes

change in lymphedema-related morbidity

Time frame: 1 month 6-9 months and 12-18 months after staging surgery for endometrial cancer